Our expertise lies in providing products to our partners, ensuring the highest quality and adherence to regulatory standards.
Commercialization of generics
Through our robust licensing and supply network, we enable our partners to expand their product portfolio and reach new markets with cost-effective generic medications.
We work closely with our partners to develop mutually beneficial agreements that drive growth and improve patient access to affordable healthcare solutions. Our valued partners have experienced the benefits of collaborating with Synthon.
Our partners
Our valued partners have experienced the benefits of collaborating with Synthon.
At Synthon, working with our partners to increase access to affordable medicines is what we do. For more information about working with us, please contact us.
With a truly global reach, Synthon operates in numerous markets around the world. Our extensive network allows us to serve patients and partners in over multiple countries, including the United States, European Union, Russia, Asia, and beyond.
A local direct-to-market sales organization comprising nearly 200,000 professionals from diverse backgrounds, Synthon already is covering 5,000 of them. Our primary focus is to serve the local high specialty pharmaceutical ecosystem, catering to both the public and private sectors. We take pride in providing a compelling and differentiated range of bioequivalent products that meet global quality standards.
With a robust portfolio of over 30 products, we are dedicated to treating patients with acute or chronic conditions. Our specialization lies in areas such as Oncology, Nephrology, Neurology, Psychiatry and Urology.
On a monthly basis, we serve more than 25 partners across the country, with a significant proportion being part of the extensive public health system. Our commitment to delivering excellence is reflected in the monthly delivery of 263,420 units of medication.
A commercial minded organization of almost 50 professionals from different backgrounds oriented to serve local pharma ecosystem, including both public and private sector by providing a compelling and differentiated offer of bioequivalent products, with a global quality standard.
Our portfolio offers 50+ products to treat patients with acute or chronic conditions; mostly in the Oncology, Central Nervous System and Urology fields.
More than 300 customers are being served in a monthly basis along the country, where most of them are part of the large public health system.
300.000 units are delivered monthly intended to treat patients.
Our team
Partner with us
At Synthon, working with our partners to increase access to affordable medicines is what we do. For more information about working with us, please contact us.